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Abstract
Background: Cadmium (Cd), a widespread environmental contaminant, and iron deficiency (ID), the most common
nutrient deficiency in the world, are known risk factors for neurodevelopmental delays, as well as other disorders, in
infants and children. Studies assessing the cumulative effects of these factors are lacking in children, despite
concerns of increased uptake of metals in the presence of ID. Here we sought to determine if blood and urine Cd
levels were elevated in ID children compared to non-ID children.
Methods: Data for 5224 children, aged 3–19 years, were obtained from the 1999–2002 NHANES. ID was defined
as ≥2 of 3 abnormal iron indicators (low serum ferritin [SF], high free erythrocyte protoporphyrin [FEP], low %
transferrin saturation [TSAT]); ID anemia (IDA) was defined as ID plus low hemoglobin (Hgb). Logistic regression was
used to evaluate associations between ID, IDA, and abnormal iron indicators and categories of blood and urine Cd.
Results: Adjusted odds of ID, IDA, low SF, and low TSAT were associated with increasing category of blood Cd but
not urine Cd. Adjusted ORs (95% CI) for blood Cd ≥0.5 μg/L versus < LOD were = 1.74 (1.30-2.34), 4.02 (1.92-8.41),
4.08 (2.36-5.89) and 1.78 (1.32-2.39), for ID, IDA, low SF, and low TSAT, respectively. Age and sex specific analyses of
blood Cd and ID/abnormal iron indicators revealed that the observed associations were strongest in females aged
16–19 years.
Conclusions: Given their shared neurotoxic effects in children, and that many people live in areas with high
burdens of both ID and Cd, more research into the complex relationships between nutrient deficiencies and
environmental toxicants is vital.
Keywords: Cadmium, Iron deficiency, Anemia, Serum ferritin, Free erythrocyte protoporphyrin, Transferrin
saturation, NHANES, CDC
Background
Cadmium (Cd) is a toxic heavy metal that naturally exists
in the earth’s crust. It has non-corrosive properties that
make it desirable for use in a number of industrial products
and processes, such as batteries, metal coatings, pigments,
and plastics [1]. Non-occupationally exposed adults and
children are exposed to Cd largely through the diet, with
secondary exposures occurring from cigarette smoking or
secondhand tobacco smoke, house dust, and industrial
emissions [1,2]. Recent reports have also found that
children may be exposed to Cd in toys and jewelry [3].
Cd accumulates in the body, mainly in the kidney, and
is excreted very slowly, at a rate of about ~0.001% per
day via the urine [4]. Exposure to Cd is typically measured
in either blood or urine. Urine Cd, with a half-life of 30
years, reflects accumulated Cd body burden [4], while
blood Cd, with a half-life of three to four months, reflects
more recent exposure [5]. Cd has been associated with
a numerous adverse health effects, including impaired
kidney function, diabetes, hypertension, osteoporosis,
and cancers in adults [2,4-7], as well as immunosup-
pression, neurotoxicity, and neurodevelopmental problems
in children [8-11].
Iron deficiency (ID) is the most common and widespread
nutritional disorder in the world [12]. It is believed to affect
over 300 million pre-school and school-aged children [13].
While highly prevalent in developing countries, it is
still a problem in many industrialized countries [14,15].
ID is associated with a multitude of health problems in
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children and adults [16]. In infants and young children,
specifically, ID has been associated with poorer phys-
ical and mental development, and reduced cognitive
function [1,13,17-20].
Dietary Cd absorption is thought to increase when iron
stores are depleted. Studies in animals have demonstrated
associations between ID and increased uptake of Cd via
the diet [21-23]. Several studies in human adults have also
found inverse associations between indicators of iron
status and Cd levels. Three studies found that Cd in
blood was inversely associated with serum ferritin (SF)
levels in women [24-26], as well as both sexes [27]. Others
have found increased urine Cd levels in pregnant women
with poor iron status, as defined by SF [28] or the ratio of
transferrin receptor to SF [29]. A recent study also found
inverse associations between total body iron and both
urine and blood Cd in women [30]. We were only able
to identify one study that examined this association in
children. Turgut and colleagues examined blood lead
(Pb), copper (Cu), Cd, SF, and hemoglobin (Hgb) levels in
a modest sample of children in Turkey (n = 256), where
ID and heavy metal exposures are common. They
found significantly higher levels of all three metals in
children with iron deficiency anemia (IDA) but not with
ID alone [31].
The aim of this study was to determine the extent to
which Cd exposure and iron status are associated in a
relatively low-exposed population of U.S. children.
Methods
Ethics statement
The National Health and Nutrition Examination Surveys
(NHANES) is a publicly available data set administered by
the National Center for Health Statistics (NCHS), part of
the U.S. Centers for Disease Control and Prevention. Writ-
ten informed consent (parents of children <18 years old or
participants ≥18 years old) and assent (children ≥12 years
old), consistent with approval by the NCHS Institutional
Review Board, were obtained prior to participation in
NHANES.
Study population
Data were from the NHANES 1999/2000 and 2001/02
study cycles [32,33]. NHANES is a cross-sectional study
designed to be representative of the health and diet of the
non-institutionalized U.S. population. For the present study,
6856 children, 19 years of age or younger, were eligible
for the blood Cd portion of the study. A subset of those
(n = 1840) had urine Cd measurements available. Children
with missing data for age, poverty income ratio, and
serum cotinine were excluded, decreasing the eligible sam-
ple size to 6039 (n = 1639 for urine subsample). Additional
exclusions were made to eliminate the influence of inflam-
mation or infection on the iron measurements (see Iron
status section of Methods for further explanation), decreas-
ing the final sample size to 5224 subjects (n = 1430 for
urine subsample).
Cadmium biomarkers
Blood and urine Cd were measured at the Environmental
Health Laboratory of the National Center for Environmental
Health (Atlanta, GA, USA). NHANES laboratory protocols
employ extensive quality assurance/quality control proce-
dures, the details of which are described elsewhere [34-37].
Blood Cd was measured in whole blood using a multi-
element atomic absorption spectrometer with Zeeman
background correction [34,35]. National Institute of Stan-
dards and Technology whole blood standard reference
materials were used for external calibration. The inter-assay
coefficients of variation for blood Cd ranged from 4.1% to
7.3% [34,35]. The limit of detection (LOD) for blood Cd
was 0.3 μg/L. Values below the LOD were assigned a value
0.2 μg/L (n = 3204), which was equal to the LOD divided
by the square root of two [38,39]. Due to the large number
of children with values below the LOD, we categorized
blood Cd into three categories for analysis as the
independent variable in the blood Cd models: <LOD,
0.3-0.4, ≥0.5 μg/L.
Urine Cd was measured in spot urine samples from a
subset of NHANES participants aged six years and older,
using inductively coupled plasma mass spectrometry [36,37].
National Institute of Standards and Technology urine
standard reference materials were used for external
calibration. The inter-assay coefficients of variation for
urine Cd ranged from 1.3% to 6.7% [36,37]. The LOD
for urine Cd was 0.06 ng/mL. Measurements below the
LOD were assigned a value of 0.04 ng/mL (n = 71), which
was equal to the LOD divided by square root of two
[40,41]. Urine Cd was also manually corrected for molyb-
denum oxide interference [40,41]. Creatinine (Cr)-adjusted
urine Cd (μg/g Cr) was created by dividing urine Cd
(ng/mL) by urinary creatinine (UCr) (ng/mL). Cr-adjusted
values are expressed here as ng/g Cr. The urine Cd distri-
bution was right-skewed, necessitating a natural-log trans-
formation, but there were urine Cd values = 0 (n = 40),
which would have been lost if a natural-log transformation
was used. Therefore, we categorized urine Cd into tertiles
for analysis as the independent variable in the urine
Cd models: ≤0.1, >0.1-0.2, >0.2 ng/mL and ≤0.7, >0.7-
1.3, >1.3 ng/g Cr.
Iron status
Details regarding the quantification of iron status indicators
are described elsewhere [38,39,42,43]. Briefly, serum ferritin
(SF) was measured using a single-incubation two-site
immunoradiometric assay from Bio-Rad Laboratories
(QuantImmune Ferritin IRMA kit) [38,39]. Free erythro-
cyte protoporphyrin (FEP) was quantitatively determined
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by molecular fluorometry using a spectrofluorometer
[39,42]. The final FEP value was expressed as μg/dL of
packed red blood cells (RBC). Percent transferrin satur-
ation (TSAT) was calculated by dividing serum iron by
total iron-binding capacity (TIBC) and multiplying by 100.
Iron and TIBC were measured on an Alpkem Flow Solu-
tions IV (rapid-flow analysis) system [39,43]. Hemoglobin
(Hgb) was quantified using a Beckman Coulter MAXM
instrument [44,45].
Iron deficiency (ID) was defined as ≥2 of 3 abnormal
iron indicators (SF, FEP, TSAT), based on age-specific
norms (Table 1) [46]. Children with a white blood cell
count above 10×109 cells/L or a C-Reactive Protein level
greater than 6 mg/L were excluded from the analysis,
due to concerns about the effects of infection and/or
inflammation on some iron measurements [47-50]. Iron
deficiency anemia (IDA) was defined as ID plus low Hgb,
based on age and sex specific norms (Table 1) [46].
Covariates
Demographic information was obtained by self-report using
computer-assisted personal interviews [51,52]. Gender was
categorized as male or female. Continuous age, in years,
was calculated using age, in months, at the time of the
NHANES physical examination. Race/ethnicity was catego-
rized into five groups: Mexican American, other Hispanic,
Non-Hispanic Black (NHB), Other/Multi-Racial, and Non-
Hispanic White (NHW). Poverty income ratio (PIR), cre-
ated by the Department of Health and Human Services to
quantify the ratio of family income to poverty [53], was
categorized into quartiles <1.00, 1.00-1.80, 1.81-3.53, ≥3.54.
These quartiles roughly represent categories for below
poverty level, low-, middle-, and high-income [53]. Serum
cotinine was measured by isotope dilution-high perform-
ance liquid chromatography/atmospheric pressure chemical
ionization tandem mass spectrometry [38,39]. We catego-
rized cotinine into <1, <1-10, and >10 ng/mL, to represent
little or no exposure to secondhand smoke (SHS), high
exposure to SHS, and likely smokers, respectively [54].
UCr, used to account for urine dilution, was measured
using a modified Jaffé rate reaction and a Beckman Instru-
ments CX3 analyzer [40,41]. UCr was used as a continuous
covariate in models with urine Cd or as the denominator
for calculating ng Cd/g Cr for urine samples.
Statistical analysis
SAS version 9.3 (SAS Institute, Cary, NC) was used for all
analyses. NHANES utilizes a complex, multistage design,
in which certain subpopulations are oversampled. Sample
weights can then be used to achieve results that are
generalizable to the U.S. population. However, when
factors employed in the formation of the sample weights,
such as gender, age, race/ethnicity, or PIR, are included
as covariates in the analysis, a weighted approach can
be inefficient [55]. Here, we opted not to use sampling
weights, instead analyzing the data as a cross-sectional
cohort analysis.
Descriptive statistics, frequencies, and correlations for all
variables of interest were examined. Based on the distribu-
tion of the variables of interest, logistic regression was
used to evaluate associations between ID, IDA, or binary
iron indicators (abnormal or normal) and categories of
blood or urine Cd exposure. Crude and adjusted (for
gender, age, race/ethnicity, PIR, and serum cotinine) models
were examined for all relationships of interest. Urine Cd
models were run two ways: with UCr as a covariate in the
model [56] and using Cr-adjusted urine Cd concentration
as the exposure.
Sensitivity analyses were completed to check the robust-
ness of the analysis. Blood and urine Cd models were run
after excluding children with serum cotinine >10 ng/mL
(likely smokers). Blood Cd models were run for the subset
of children with both urine and blood Cd data. Continu-
ous iron indicators (natural-log[SF], natural-log[FEP], and
TSAT) were used in logistic regression models of binary
blood Cd (≥LOD vs. <LOD). Continuous urine Cd was
used in logistic regression models of ID, IDA, low SF, high
FEP, and low TSAT. Natural-log[SF], natural-log[FEP], and
TSAT were used in linear regression models of continuous
urine Cd/g Cr.
Age and sex-specific analyses of the blood Cd/iron status
associations were also conducted. Several methods were
used, including stratified frequencies, stratified models, and
interaction terms. Analysis groups included boys or girls
ages 3–11, 12–15, or 16–19 years, for a total of six groups.
These groups were chosen using the same age/sex cat-
egories as the iron indicator cut-offs [46], though here we
combined the two youngest age groups for simplicity.
Crude and adjusted stratified models were run as before.
However, instead of three categories of blood Cd, binary
blood Cd (<LOD or ≥ LOD) was used to reduce the likeli-
hood of having analysis groups with very low numbers. In
an effort to be more parsimonious, other covariates were
not included in these analyses.
Results
There were no significant differences in demographics
between those excluded from the analysis due to missing
data and those included, with the exception of age. The
Table 1 Cut-off values for abnormal iron indicators and
Hgb used to define ID and IDA
Age (years) SF (μg/L) TSAT (%) FEP (μg/dL) Hgb (g/dL)
Girls Boys
3-5 <10 <12 >70 <11.2 <11.2
6-11 <12 <14 >70 <11.8 <11.8
12-15 <12 <14 >70 <11.9 <12.6
16-19 <12 <15 >70 <12.0 <13.6
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excluded group was slightly younger, since serum cotinine
was only available in children three years of age and older.
The mean, 95th percentile, and maximum for blood Cd
were 0.30, 0.40, and 4.00 μg/L, respectively. For urine Cd,
the mean, 95th percentile, and maximum were 0.16, 0.32,
and 1.80 ng/mL, respectively. The mean, 95th percentile,
and maximum for Cr-adjusted urine Cd were 1.19, 2.14,
and 14.49 ng/g Cr, respectively. Additional population
characteristics can be found in Table 2. The prevalence
of ID was 7.0% (n = 365); IDA was observed in 1.5%
(n = 77). 29.2% of children (n = 1603) had at least one
abnormal iron indicator: 8.1% (n = 422) had low SF,
10.8% (n = 563) had high FEP, 17.6% (n = 920) had
low TSAT, and 5.2% (n = 269) had low Hgb. Table 3
shows frequencies for ID, IDA, and abnormal iron indica-
tors. Blood and urine Cd were weakly but significantly
correlated; Spearman rank ρ = 0.25, p < 0.0001 (ρ = 0.20,
p < 0.0001 for Cr-adjusted urine Cd). Overall, ID was most
common in girls, among Mexican American children, and
was found to increase in adolescence. Blood Cd increased
with serum cotinine (Spearman rank ρ = 0.20, p < 0.0001)
and also with age (Spearman rank ρ = 0.32, p < 0.0001).
Blood Cd was highest in boys, Mexican American, and
NHB children. Urine Cd was also highest in NHB and
Mexican American children, and also increased with age
(Spearman rank ρ = 0.27, p < 0.0001).
Crude and adjusted logistic regression results can be
found in Table 4. Odds of ID, IDA, low SF, and low TSAT
were associated with increasing category of blood Cd.
Adjusted odds ratios (ORs) and 95% confidence intervals
(95% CI) for high blood Cd (≥0.5 μg/L) versus < LOD were
1.74 (1.30-2.34), 4.02 (1.92-8.41), 4.08 (2.36-5.89), and
1.78 (1.32-2.39), for IDA, ID, low SF, and low TSAT, re-
spectively. The p-values for trend were also statistically
significant for all four models. Results for urine Cd were
less striking, though crude odds of ID and low SF were
associated with increasing category of urine Cd (per
gram Cr). However, these associations for urine Cd did
not remain statistically significant after adjustment for
other covariates.
Sensitivity analyses confirmed the robustness of the blood
Cd results. The exclusion of likely smokers did not sig-
nificantly change the associations between blood Cd
and increased odds of ID, IDA, low SF, and low TSAT
(Additional file 1: Table S1). Analysis of the blood Cd
associations in the subset of children with both urine
and blood Cd data also did not meaningfully affect the
results (Additional file 1: Table S2). Replacement of
categorical variables with continuous ones also produced
similar trends, statistical significance, and directions of
association as the categorical analyses (Additional file 1:
Table S3). The only exception was that the low TSAT/
blood Cd relationship lost statistical significance when
continuous TSAT was used (Additional file 1: Table S3).
Age and sex-stratified frequencies as well as stratified
model results are shown in Table 5. Girls, 12–19 years
old, had higher frequencies of ID, low SF, high FEP, and
low TSAT than boys of the same age. Compared to boys,
girls aged 3–11 years had significantly higher odds of hav-
ing low SF if they had blood Cd ≥ LOD; OR (95% CI) = 2.03
(1.08-3.83). Girls aged 12–15 years with blood Cd ≥ LOD
had significantly higher odds of having ID, low SF, and low
TSAT; ORs (95% CI) = 2.13 (1.39-3.26), 2.63 (1.77-3.89),
and 1.46 (1.05-2.03), respectively. Girls aged 16–19 years
had increased odds of ID and abnormal iron indicators for
all iron indicators; ORs (95% CI) = 2.36 (1.58-3.63), 3.12
(2.08-4.68), 1.62 (1.11-2.35), and 1.55 (1.10-2.16), for ID,
low SF, high FEP, and low TSAT, respectively. Boys aged
12–15 years with high blood Cd also had increased odds
of having ID and low SF; ORs (95% CI) = 2.35 (1.21-4.58)
and 2.62 (1.30-4.93), respectively. The ID model for 16- to
19-year-old boys did not converge due to very low numbers
of ID.
Discussion
With increasing levels of blood Cd, the odds of ID, IDA,
low SF, and low TSAT also increased. These associations
remained significant, regardless of whether active smokers
were excluded, the dataset was restricted to a smaller
number of participants, categorical or continuous iron
Table 2 Characteristics of the study population
N (%)
Gender (F) 2502 (47.9%)
Age (years)
3-5 538 (10.3%)
6-11 1429 (27.4%)
12-15 1695 (32.5%)
16-19 1562 (29.9%)
Race/ethnicity
Mexican American 1791 (34.3%)
Other Hispanic 243 (4.7%)
Non-Hispanic Black 1582 (30.3%)
Other/Multi Racial 213 (4.1%)
Non-Hispanic White 1395 (26.7%)
Poverty Index Ratio (PIR)
<1.00 (below poverty level) 1739 (33.3%)
1.00-1.80 (low income) 1260 (24.1%)
1.81-3.53 (middle income) 1220 (23.4%)
3.54-5.00 (high income) 1005 (19.2%)
Serum cotinine (ng/mL)
>10 (likely smoker) 428 (8.2%)
1-10 (high SHS exposure) 714 (13.7%)
<1 (no/low SHS exposure) 4082 (78.1%)
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indicators were used, and exposure and outcome were
reversed. These relations were not observed for urine
Cd in models adjusted for relevant covariates. Girls,
12–19 years old, had higher frequencies of ID, low SF,
high FEP and low TSAT than boys of the same age.
Young girls had increased odds of low SF with high
blood Cd. Boys and girls, ages 12–15, had increased
odds of ID and low SF with high blood Cd, and 16- to
19-year-old girls with high blood Cd had increased
odds of ID, low SF, high FEP, and low TSAT.
The results for blood Cd in this study are consistent
with previous epidemiological findings, all of which found
Table 3 Frequencies of ID, IDA, and abnormal iron indicators
Exposure ID IDA Low SF High FEP Low TSAT
N N (%) N (%) N (%) N (%) N (%)
Blood Cd (ug/L)
High (≥0.5) 512 58 (11.3%) 17 (3.3%) 69 (13.5%) 62 (12.1%) 106 (20.7%)
Med. (0.3-0.4) 1508 151 (10.0%) 32 (2.1%) 184 (12.2%) 186 (12.3%) 291 (19.3%)
Low (<LOD) 3204 156 (4.9%) 28 (0.9%) 169 (5.3%) 315 (9.8%) 523 (16.3%)
Total 5224 365 (7.0%) 77 (1.5%) 422 (8.1%) 563 (10.8%) 920 (17.6%)
Urinary Cd (ng/mL)
High (>0.2) 471 40 (8.5%) 10 (2.1%) 88 (18.7%) 57 (12.1%) 48 (10.2%)
Med. (>0.1 to 0.2) 487 33 (6.8%) 6 (1.2%) 93 (19.1%) 54 (11.1%) 40 (8.2%)
Low (≤0.1) 472 29 (6.1%) 5 (1.1%) 91 (19.3%) 51 (10.8%) 33 (7.0%)
Total 1430 102 (7.1%) 21 (1.5%) 272 (19.0%) 162 (11.3%) 121 (8.5%)
Urinary Cd (ng/g Cr)
High (>1.3) 467 45 (9.6%) 7 (1.5%) 102 (21.8%) 62 (13.3%) 52 (11.1%)
Med. (>0.7 to 1.3) 489 30 (6.3%) 6 (1.2%) 80 (16.4%) 54 (11.0%) 35 (7.2%)
Low (≤0.7) 474 27 (5.7%) 8 (1.7%) 90 (19.0%) 46 (9.7%) 34 (7.2%)
Total 1430 102 (7.1%) 21 (1.5%) 272 (19.0%) 162 (11.3%) 121 (8.5%)
Table 4 Logistic regression model resultsa
Blood Cd Urinary Cd/g Cr Urinary Cd
Outcome Exposure OR (95% CI) OR (95% CI) OR (95% CI)
Crude Adjustedb Crude Adjustedb Crudec Adjustedd
ID High vs. low Cd 2.50 (1.82-3.43) 2.78 (1.87-4.12) 1.77 (1.08-2.90) 1.37 (0.81-2.34) 1.64 (0.91-2.97) 1.21 (0.64-2.28)
Med. vs. low Cd 2.17 (1.72-2.74) 1.90 (1.48-2.43) 1.08 (0.63-1.85) 1.01 (0.58-1.77) 1.17 (0.69-2.00) 1.06 (0.61-1.86)
p-trend <0.0001 <0.0001 0.02 0.22 0.10 0.56
IDA High vs. low Cd 3.90 (2.11-7.17) 4.02 (1.92-8.41) 1.00 (0.46-2.19) 0.79 (0.35-0.75) 1.78 (0.55-5.73) 0.83 (0.24-2.82)
Med. vs. low Cd 2.46 (1.48-4.10) 2.00 (1.17-3.42) 0.82 (0.35-1.89) 0.80 (0.34-1.89) 1.10 (0.35-3.48) 0.83 (0.25-2.77)
p-trend <0.0001 0.0001 0.86 0.48 0.33 0.77
Low SF High vs. low Cd 2.80 (2.08-3.77) 4.08 (2.36-5.89) 1.62 (1.03-2.55) 1.42 (0.88-2.29) 1.91 (1.10-3.31) 1.63 (0.91-2.92)
Med. vs. low Cd 2.50 (2.02-3.11) 2.38 (1.89-3.00) 1.00 (0.61-1.63) 0.99 (0.59-1.63) 1.30 (0.80-2.13) 1.28 (0.76-2.14)
p-trend <0.0001 <0.0001 0.03 0.14 0.02 0.1
High FEP High vs. low Cd 1.26 (0.95-1.69) 1.36 (0.95-1.95) 1.42 (0.95-2.14) 1.02 (0.66-1.58) 1.47 (0.91-2.38) 1.12 (0.67-1.88)
Med. vs. low Cd 1.29 (1.06-1.56) 1.07 (0.88-1.32) 1.16 (0.76-1.75) 0.99 (0.64-1.53) 1.14 (0.75-1.73) 0.99 (0.64-1.54)
p-trend 0.013 0.133 0.09 0.91 0.19 0.67
Low TSAT High vs. low Cd 1.34 (1.06-1.69) 1.74 (1.30-2.34) 1.19 (0.87-1.64) 1.07 (0.77-1.49) 1.12 (0.76-1.65) 0.94 (0.62-1.41)
Med. vs. low Cd 1.23 (1.05-1.44) 1.26 (1.07-1.48) 0.84 (0.60-1.16) 0.82 (0.58-1.15) 1.05 (0.75-1.46) 1.02 (0.72-1.43)
p-trend 0.002 <0.0001 0.27 0.67 0.57 0.76
aCrude and adjusted odds of ID, IDA, low SF, high FEP, and low TSAT for children with high and medium Cd versus low Cd.
bModels adjusted for gender, age, race/ethnicity, PIR, and serum cotinine.
cModels adjusted for UCr only.
dModels adjusted for gender, age, race/ethnicity, PIR, serum cotinine, and UCr.
Silver et al. Environmental Health 2013, 12:117 Page 5 of 9
http://www.ehjournal.net/content/12/1/117
a significant inverse associations between varying indicators
of iron status and blood Cd levels [24-27,30,31]. The urine
Cd results, however, were not significant after adjustment
for covariates. Three previous studies have found significant
associations between iron levels and urine Cd [28-30],
though all were in adults, and urine Cd levels were
considerably higher (urine Cd means of 242 ng/g Cr [30]
and 0.31 μg/L [29], compared to our reported means of
1.19 ng/g Cr and 0.16 μg/L). We found that urine Cd was
correlated with age (Spearman rank ρ = 0.27, p < 0.0001),
consistent with Cd accumulating in the kidney over a
time. Since Cd accumulates in the kidney, it is possible
that our study population of children was too young to
have urine Cd concentrations high enough detect a clear
association. Alternatively, urine Cd may not be an ideal
biomarker when considering the association of Cd with
current iron status, since urine Cd represents a more
long-term measure of Cd exposure [4]. While indicators
used to determine iron status are fairly stable on a day-to-
day basis [57,58], they change markedly with development
over longer periods of time and with the onset of puberty.
Blood Cd, a measure of more recent Cd exposure [5], may
therefore be a more appropriate biomarker for assessing
relations with iron status.
To our knowledge, sex and age-specific results have
not been reported prior to this analysis, as the majority of
related studies to date have been only among adult females.
Still, our finding that older girls are the most likely group to
have ID or have abnormal iron indicators is not surprising,
given that girls who have reached menarche are more likely
to be ID than younger or less mature girls [15,59]. The
significant associations between blood Cd and ID and
low SF observed for boys aged 12–15, were somewhat
surprising. This is not a group commonly studied in
the ID field and we could find no precedent to which we
could compare these findings. The results require replica-
tion, since the number of 12- to 15-year-old boys with ID
and Cd ≥ LOD was small (n = 23).
Studies of Cd exposure and iron status among children
are limited. The only study we could identify compared
blood Cd levels in healthy, ID, and IDA children in Turkey
[31]. ID was defined as low SF levels and IDA as low Hgb,
in addition to low SF. The investigators found significantly
higher levels of blood Cd in children with IDA, as com-
pared to healthy children, but did not find a statistically
significant difference in Cd levels when comparing ID
children with healthy children, using ANOVA [31]. Our re-
sults extend the Turkey study by using a multi-indicator
model for defining ID, more sophisticated data analyses,
and a much larger sample size (n = 5224 compared to 256).
Although there has been little research on ID and Cd in
children, several studies have examined similar relation-
ships between ID and blood Pb and have found significant
inverse associations between Pb and ID [60-62]. It is
possible that Pb and Cd, both divalent metals, may share a
similar mechanism of uptake. One such proposed mech-
anism for the apparent increase of divalent metals in the
presence of ID is increased expression of divalent metal
transporter 1 (DMT1) when iron status is compromised
[21,63]. Higher levels of DMT1, in theory, help the body
to absorb more iron from the intestine. If Cd or other
divalent metals are present in the diet, upregulation of
DMT1 due to ID may also contribute to the increased
uptake of toxic heavy metals.
The present analysis has several noteworthy strengths.
To our knowledge, this is the first study to demonstrate
an association between ID and blood Cd in children in
the U.S. We used the multiple indicator ferritin model
to determine iron status, which takes into account the
levels of three iron indicators: SF, FEP, and TSAT. This
represents an improvement over some previous studies,
many which have used SF levels alone to determine iron
status [24,25,27,31]. Recently, some researchers have
advocated the use of another multi-indicator model for
iron status, “body iron”, which yields a single parameter
ranging from iron excess to iron deficit [47]. We were
unable to use the body iron model for this study, since
serum transferrin receptor, which is needed to calculate
body iron, is unavailable in NHANES prior to 2003. We
chose NHANES 1999/2000 and 2001/02 cycles because
Table 5 Age and sex stratified frequencies and logistic regression model resultsa
ID Low SF High FEP Low TSAT
Stratification
group
N N (%) OR (95% CI) N (%) OR (95% CI) N (%) OR (95% CI) N (%) OR (95% CI)
Girls 3–11 yrs 945 41 (4.3%) 1.62 (0.83-3.20) 44 (4.7%) 2.03 (1.08-3.83) 92 (9.7%) 1.31 (0.81-2.13) 167 (17.7%) 0.93 (0.62-1.39)
Boys 3–11 yrs 1022 36 (3.5%) 0.97 (0.45-2.09) 45 (4.4%) 1.19 (0.62-2.31) 78 (7.6%) 0.93 (0.55-1.60) 182 (17.8%) 1.25 (0.87-1.78)
Girls 12–15 yrs 859 97 (11.3%) 2.13 (1.39-3.26) 119 (13.9%) 2.63 (1.77-3.89) 136 (15.8%) 1.29 (0.89-1.88) 194 (22.6%) 1.46 (1.05-2.03)
Boys 12–15 yrs 836 38 (4.6%) 2.35 (1.21-4.58) 43 (5.1%) 2.62 (1.39-4.93) 65 (7.8%) 0.92 (0.54-1.54) 102 (12.2%) 1.19 (0.78-1.81)
Girls 16–19 yrs 698 145 (20.8%) 2.36 (1.58-3.63) 161 (23.1%) 3.12 (2.08-4.68) 155 (22.2%) 1.62 (1.11-2.35) 208 (29.8%) 1.55 (1.10-2.16)
Boys 16–19 yrs 864 8 (0.9%) b 10 (1.2%) 1.7 (0.44-6.62) 37 (4.3%) 0.95 (0.49-1.84) 67 (7.8%) 1.65 (0.96-2.81)
aUnadjusted odds of ID, low SF, high FEP, and low TSAT for children with blood Cd ≥ LOD versus blood Cd < LOD.
bModel did not converge.
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we wanted to assess the relationship between Cd and ID
in children of both sexes and all age ranges. In 2003,
NHANES stopped taking iron measurements for children
of all ages and limited their analyses to children 1–5 years
and females 12 years and older. Therefore, for our analysis
we were limited to just the two early cycles of continuous
NHANES. The primary limitation to using SF alone, or
as part of the ferritin model, is the possible influence
of infection or chronic inflammation on SF levels. To
address this issue, we excluded children with signs of
infection or inflammation, as indicated by a high white
blood cell count or high C-reactive protein levels. In
an effort to further improve the validity of our findings,
we also conducted several sensitivity analyses, which
revealed our findings were robust. Finally, we had a large
sample size (n = 5224) and looked at the entire age range
of children (with the exception of 1 and 2 year olds who
were excluded due to missing serum cotinine values),
which had not been examined before.
As with all cross-sectional analyses, this study is limited
in that we cannot demonstrate causation or temporality.
We do not know if poor iron status led to increased
uptake of Cd or higher concentrations of Cd decreased
iron absorption or storage. Additionally, we do not have
any information regarding individual genetic susceptibility,
since genetic polymorphisms of iron-related genes can
be an important factor in the uptake of heavy metals,
such as Cd and Pb [28,64-67]. Finally, future studies
should include infants, who were excluded here due to
missing data.
Conclusions
In conclusion, in U.S. children aged 3–19 years, odds of ID
and IDA increased with blood Cd, a biomarker of recent
Cd exposure. Odds of low SF and low TSAT were also
found to increase with blood Cd. Sex and age-specific
analyses revealed that odds of ID, IDA, and abnormal
iron indicators were highest in adolescent females.
Given their shared neurotoxic effects in children, and
that many children live in areas with high burdens of both
ID and heavy metals, more research into the complex rela-
tionships between nutrient deficiencies and environmental
exposures is vital.
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